SCHEMBL13586986

SCHEMBL13586986

Cc1ccc(C(C)NNCl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ CHRNA7 P36544 1/20 0.38
▸ ACHE P22303 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ HTR1A P08908 2/20 0.35
▸ HTR7 P34969 2/20 0.35
▸ HTR6 P50406 2/20 0.35
▸ MAPT P10636 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ GRIA4 P48058 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19286213 0.83 SMN1; SMN2 (0.42) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL12654171 0.79 HSD17B10 (0.46) SMN1; SMN2MEN1KMT2ANPSR1HTR1A
SCHEMBL2662574 0.75 TYR (0.55) SMN1; SMN2KDM4EALDH1A1GAAGRIA4
SCHEMBL178538 0.73 ALDH1A1 (0.52) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL8284259 0.73 ALDH1A1 (0.52) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL8285887 0.73 ALDH1A1 (0.52) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL2663534 0.71 LMNA (0.41) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL14305054 0.71 SMN1; SMN2 (0.41) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL6114224 0.71 SMN1; SMN2 (0.41) SMN1; SMN2CHRNA7ACHETDP1TAS1R3
SCHEMBL11947945 0.71 LMNA (0.41) SMN1; SMN2CHRNA7ACHETDP1TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625938-B2 Substituted pyrazoles, compositions containing such compounds and methods of use MERCK & CO., INC. (US) 2009-12-01 — — US disclosed
US-20080108620-A1 Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use MERCK & CO., INC. (US) 2008-05-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108620-A1 Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use GLP1R, GCGR, GPR119 SMN1; SMN2 4364/4885CHRNA7 2740/4885ACHE 3929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback